These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7718644)

  • 21. Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells.
    Somasundaram R; Advani SH; Gangal SG
    Cancer Immunol Immunother; 1988; 27(2):183-9. PubMed ID: 3262015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic activity of lymphocyte subpopulations against autologous tumour cells in patients with myeloid leukaemias and preleukaemic disorders.
    Szabó B; Váczi L; Tóth FD; Kiss J; Kiss A; Rák K
    Acta Microbiol Hung; 1988; 35(1):25-33. PubMed ID: 3260709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
    Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
    Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive role of CD11b
    Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW
    Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent approaches to induction of cytotoxic lymphocytes against leukemia.
    Lotzová E
    Leukemia; 1993 Aug; 7 Suppl 2():S69-74. PubMed ID: 8361237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
    Bruserud O; Ulvestad E
    J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [T-cell immunity against autologous leukemic cell mediated by in vitro bone marrow-derived dendritic cell from patients with acute myeloid leukemia in complete remission].
    He X; You S; Bian S
    Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):629-32. PubMed ID: 16200709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
    Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
    Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia.
    Faber LM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    J Exp Med; 1992 Nov; 176(5):1283-9. PubMed ID: 1402674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model.
    Ma Q; Wang C; Jones D; Quintanilla KE; Li D; Wang Y; Wieder ED; Clise-Dwyer K; Alatrash G; Mj Y; Munsell MF; Lu S; Qazilbash MH; Molldrem JJ
    Cytotherapy; 2010 Dec; 12(8):1056-62. PubMed ID: 20735170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia.
    Narita M; Takahashi M; Liu A; Nikkuni K; Furukawa T; Toba K; Koyama S; Takai K; Sanada M; Aizawa Y
    Exp Hematol; 2001 Jun; 29(6):709-19. PubMed ID: 11378266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.
    Berthon C; Driss V; Liu J; Kuranda K; Leleu X; Jouy N; Hetuin D; Quesnel B
    Cancer Immunol Immunother; 2010 Dec; 59(12):1839-49. PubMed ID: 20814675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
    Margolin KA; Wright C; Forman SJ
    Leukemia; 1997 May; 11(5):723-8. PubMed ID: 9180298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CD226-ERK1/2-LAMP1 pathway is an important mechanism for Vγ9Vδ2 T cell cytotoxicity against chemotherapy-resistant acute myeloid leukemia blasts and leukemia stem cells.
    Wu K; Wang LM; Liu M; Xiu Y; Hu Y; Fu S; Huang H; Xu B; Xiao H
    Cancer Sci; 2021 Aug; 112(8):3233-3242. PubMed ID: 34107135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
    Patel SS; Thiele DL; Lipsky PE
    J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications.
    Beauchemin V; Villeneuve L; Rodriguez-Cimadevilla JC; Rajotte D; Kenney JS; Clark SC; Hoang T
    J Cell Physiol; 1991 Sep; 148(3):353-61. PubMed ID: 1918169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells fused with core binding factor-beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes.
    Banat GA; Usluoglu N; Hoeck M; Ihlow K; Hoppmann S; Pralle H
    Br J Haematol; 2004 Aug; 126(4):593-601. PubMed ID: 15287954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases.
    Slingluff CL; Darrow T; Vervaert C; Quinn-Allen MA; Seigler HF
    J Natl Cancer Inst; 1988 Sep; 80(13):1016-26. PubMed ID: 3261800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.
    Archimbaud E; Thomas X; Campos L; Fiere D; Doré JF
    Leuk Res; 1992; 16(6-7):673-80. PubMed ID: 1378919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
    J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.